Prophylactic Sodium Supplementation for Children Hospitalized With Pneumonia

NCT06951347 | Completed

• 1 other identifier: HM000174
• Study Type: interventional
• Target: 140
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this clinical trial is to study the impact of sodium supplementation on hospital outcomes of children with pneumonia. It aims to answer:

• Does sodium supplementation lower the length of hospital stay in children with pneumonia?
• Does potassium supplementation lower the length of hospital stay in children with pneumonia? Researchers will compare the intervention arm to the control arm to see if the intervention lowers the length of hospital stay. Participants will:
• Take one sachet of oral rehydration solution (ORS) every day for 3 days.

Conditions

Childhood Pneumonia

Outcome Measures

Primary Outcomes (1)

• The difference in hospital length of stay between hospitalized children with pneumonia who received oral rehydration solution and those who did not receive it

  Evaluation of effect of oral rehydration solution supplementation by assessing the length of hospital stay

  Children will be followed until discharge from the hospital, an average of one week.

Study Arms (2)

Intervention Group

EXPERIMENTAL

Dietary Supplement: Oral Rehydration Solution

Control Group

NO INTERVENTION

Interventions

Oral Rehydration Solution DIETARY_SUPPLEMENT

one sachet every day for 3 days

Intervention Group

Eligibility Criteria

• Age: 1 Month - 5 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17)

You may qualify if:

• Infants and children aged between 1 month and 5 years.
• Patients diagnosed with pneumonia according to World Health Organization (WHO) criteria.

You may not qualify if:

• Children with other comorbidities.
• Those whose parents will show disapproval for the participation of the study.
• Children on medications that affect sodium and potassium levels.

Sponsors & Collaborators

• General Organization for Teaching Hospitals and Institutes: lead

Study Sites (1)

Mataria Teaching Hospital

Cairo, Egypt

Location

MeSH Terms

Interventions

World Health Organization oral rehydration solution

Study Officials

• Marwa Taha, MD

  Mataria Teaching Hospital, General Organization for Teaching Hospitals and Institutes, Cairo, Egypt

  PRINCIPAL INVESTIGATOR

• Hoda Atef Abdelsattar Ibrahim, MD

  Faculty of Medicine, Cairo University, Cairo, Egypt

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: DOUBLE
• Who Masked: INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Fellow of Pediatrics, Mataria Teaching Hospital (Principal Investigator)

Study Record Dates

• First Submitted: April 19, 2025
• First Posted: April 30, 2025
• Study Start: May 1, 2025
• Primary Completion: June 1, 2025
• Study Completion: June 5, 2025
• Last Updated: September 22, 2025

Record last verified: 2025-09

Locations

EG (1)